Follow
Julie Methot
Julie Methot
Verified email at pha.ulaval.ca
Title
Cited by
Cited by
Year
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
D Gaudet, J Méthot, S Déry, D Brisson, C Essiembre, G Tremblay, ...
Gene therapy 20 (4), 361-369, 2013
4612013
Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity
BA Hamelin, A Bouayad, J Méthot, J Jobin, P Desgagnés, P Poirier, ...
Clinical Pharmacology & Therapeutics 67 (5), 466-477, 2000
1782000
Gene therapy for lipoprotein lipase deficiency
D Gaudet, J Méthot, J Kastelein
Current opinion in lipidology 23 (4), 310-320, 2012
1752012
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency
D Gaudet, J de Wal, K Tremblay, S Déry, S van Deventer, A Freidig, ...
Atherosclerosis Supplements 11 (1), 55-60, 2010
1482010
Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPLS447X) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene …
V Ferreira, J Twisk, K Kwikkers, E Aronica, D Brisson, J Methot, H Petry, ...
Human gene therapy 25 (3), 180-188, 2014
1372014
Long-term retrospective analysis of gene therapy with alipogene tiparvovec and its effect on lipoprotein lipase deficiency-induced pancreatitis
D Gaudet, ES Stroes, J Methot, D Brisson, K Tremblay, SJ Bernelot Moens, ...
Human gene therapy 27 (11), 916-925, 2016
1072016
Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women
BA Hamelin, J Méthot, M Arsenault, S Pilote, P Poirier, S Plante, P Bogaty
The American journal of medicine 114 (7), 599-602, 2003
772003
Etiology and risk of lactescent plasma and severe hypertriglyceridemia
K Tremblay, J Méthot, D Brisson, D Gaudet
Journal of clinical lipidology 5 (1), 37-44, 2011
722011
Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics
D Brisson, J Méthot, K Tremblay, M Tremblay, P Perron, D Gaudet
Pharmacogenetics and genomics 20 (12), 742-747, 2010
242010
The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women
J Méthot, BA Hamelin, M Arsenault, P Bogaty, S Plante, P Poirier
Menopause 13 (6), 959-966, 2006
242006
Salivary pH as a marker of plasma adiponectin concentrations in women
M Tremblay, Y Loucif, J Methot, D Brisson, D Gaudet
Diabetology & metabolic syndrome 4, 1-7, 2012
232012
ACE-DD genotype is associated with the occurrence of acute coronary syndrome in postmenopausal women
J Méthot, BA Hamelin, P Bogaty, M Arsenault, S Plante, P Poirier
International journal of cardiology 105 (3), 308-314, 2005
212005
On-site management of investigational products and drug delivery systems in conformity with Good Clinical Practices (GCPs)
J Méthot, D Brisson, D Gaudet
Clinical trials 9 (2), 265-271, 2012
102012
Obesity: how to define central adiposity?
J Méthot, J Houle, P Poirier
Expert Review of Cardiovascular Therapy 8 (5), 639-644, 2010
102010
No-storage wind-diesel system: Mechanical modeling based on power flow models
H Ibrahim, J Lefebvre, JF Methot, JS Deschenes
2011 IEEE Electrical Power and Energy Conference, 17-22, 2011
82011
Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings
P Pradhan, M Lavallée, S Akinola, FR Escobar Gimenes, A Bérard, ...
Journal of Applied Biomedicine 21 (2), 59-66, 2023
72023
The beta-1 adrenergic antagonist, atenolol, decreases acylation stimulating protein, exercise capacity and plasma free fatty acids in men with type 2 diabetes
J Smith, A Ferland, J Methot, P Brassard, S Lacroix, P Poirier, K Cianflone
Nutrition, metabolism and cardiovascular diseases 22 (6), 495-502, 2012
72012
L’ABC de la révision par les pairs
E Charlebois, L Mallet, J Méthot
Pharmactuel 42 (1), 2009
72009
The relationship of the occurrence of acute coronary events in women to the timing of their menstrual cycle
J Methot, P Bogaty, P Poirier, M Arsenault, S Pilote, S Plante, BA Hamelin
Circulation 102 (18), 613-613, 2000
72000
Modifications in Triglyceride-Rich Lipoprotein Metabolism Induced by Alipogene Tiparvovec (AAV1-LPLS447X Gene Therapy) Correlate With Clinical Benefit in …
D Gaudet, J Methot, C Gagńe, S Déry, K Tremblay, J De Wal, J Twisk, ...
Circulation 122 (suppl_21), A21355-A21355, 2010
52010
The system can't perform the operation now. Try again later.
Articles 1–20